Company profile
MannKind company profile
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product candidate, AFREZZA(R), is in the late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. It maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind.
Business identity
- Website
- http://mannkindcorp.com
- Phone number
- (661)775-5300
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 251-500 employees
- Revenue range
- $10M-$100M
- Founded
- 2001-01-01, Year
Headquarters
- Headquarters
- Hotevilla-Bacavi, Arizona, United States
- Postal code
- 91355
- Country code
- US
- Continent
- North America